CLINICAL_TRIALS ClinicalTrials.gov record update

A Double-blind, Parallel Group, Randomised, Placebo Controlled Study of Efficacy and Safety of Circadin® 2 mg in the Treatment of Insomnia Patients With Low Endogenous Melatonin

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00397189
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:56.355545+00:00
Published At: 2011-03-28T00:00:00+00:00
Record Updated At: 2018-05-01
Results Posted At: 2011-03-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Insomnia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-05-01"
protocolSection.identificationModule.nctId: "NCT00397189"
protocolSection.identificationModule.officialTitle: "A Double-blind, Parallel Group, Randomised, Placebo Controlled Study of Efficacy and Safety of Circadin\u00ae 2 mg in the Treatment of Insomnia Patients With Low Endogenous Melatonin"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2011-03-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.